Navigation Links
New lymphoma therapy may be more effective with fewer side effects
Date:11/3/2010

NEW YORK (Nov. 3, 2010) -- Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin's lymphoma that accounts for approximately 40 percent of lymphomas among adults. If left untreated, it is fatal. The existing treatments have a cure rate that is slightly over 50 percent but destroy healthy cells along with the cancer cells.

Researchers at Weill Cornell Medical College have found a combination therapy that is more effective than traditional treatments and is able to kill the cancer cells without harm to surrounding tissues. In a paper published in the Journal of Clinical Investigation on Nov. 1, they report that by targeting a key lymphoma-causing factor called BCL6 with a specific inhibitor called RI-BPI in combination with either a histone deacetylases (HDAC) inhibitor or with a heat shock protein (Hsp90) inhibitor, they were able to suppress and in some cases eradicate human DLBCL in mice. The researchers said their findings provide the basis for rational, targeted combinational therapy for patients with DLBCL.

Dr. Ari Melnick, associate professor of medicine and director of the Raymond and Beverly Sackler Center for Biomedical and Physical Sciences at Weill Cornell Medical College, and his colleagues have been studying ways to kill lymphoma cancer cells more effectively and efficiently than standard treatments.

"Lymphomas are not easy to treat. The standard treatment using monoclonal antibodies and chemotherapy does not work for all patients and can cause undesirable side effects," says Dr. Melnick.

B cells are a type of white blood cell that produces antibodies to fight infections. BCL6 is a master regulatory factor that plays a critical role in keeping lymphoma cells alive. Dr. Melnick's study showed that therapeutic targeting of BCL6 with RI-BPI turned on another factor called EP300, a molecular switch that itself can turn on proteins that can restrain lymphoma cell growth and turn off othe
'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New class of drug kills lymphoma cells
2. Vitamin K may protect against developing non-Hodgkins lymphoma, say Mayo Clinic researchers
3. Scott & White Healthcare clinical trials target lymphoma, leukemia
4. Lifestyle factors significantly impact survival of non-Hodgkins lymphoma patients, study finds
5. Lifestyle Affects Survival in Non-Hodgkins Lymphoma
6. Study identifies promising treatment for aggressive lymphoma
7. Study shows Hodgkin lymphoma survivors lack post-treatment screening for other cancers
8. Lymphoma Survivors Often Miss Out on Follow-Up
9. Lymphoma patients with cardiovascular disease have increased risk of cardiac hospitalization
10. Study makes exciting progress in elucidating the mechanisms of bortezomib in lymphoma
11. Scott & White Healthcare study aimed at T-cell lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Long Island, N.Y. (PRWEB) June 02, 2015 ... to refer to computer generated imagery overlaid on the ... and gone but Vein Visualization, which displays a map ... has shown a steady growth in adoption. , AccuVein, ... a 40% year over year growth rate and such ...
(Date:6/2/2015)... “ Radaris ” was featured on NewsWatch as part ... latest and coolest applications on the market for iOS, Android, ... expert, conducted the app review and shared with viewers can ... person. , According to Psychology Today, humans are a curious ... that curiosity is a part of human development. People are ...
(Date:6/2/2015)... FL (PRWEB) June 02, 2015 MedPro ... staffing services to healthcare facilities, today announced the worldwide ... and effective mobile tool to help candidates find best ... Glassdoor survey released in 2014, 9 in 10 job ... during their job search. , The MedPro Top Jobs ...
(Date:6/2/2015)... OR (PRWEB) June 02, 2015 ZOOM+, ... of ZOOM+ Performance Health Insurance, announced today the opening ... Clean White 57 - a three-in-one complete dental exam, ... Clean Jr. for kids. Like all ZOOM+ services, ZOOM+Smile ... , “Why shouldn’t the dentist office be as inviting ...
(Date:6/2/2015)... DiaTech Oncology, provider of CorrectChemo®, the ... help oncologists provide personalized cancer treatment, has gained ... for its laboratories in the U.S. and Canada. ... the ‘Good Housekeeping’ seal of approval,” says Robert ... DiaTech. “It’s a rigorous inspection that confirms our ...
Breaking Medicine News(10 mins):Health News:Vein Visualization Emerges as Premier Augmented Reality Application 2Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:MedPro Healthcare Staffing Launches New MedPro Top Jobs App To Facilitate Job Search For Healthcare Professionals 2Health News:ZOOM+ Opens Its First On-Demand ZOOM+Smile Studio and Reinvents the Dental Exam 2Health News:DiaTech Oncology Gains College of American Pathologists Accreditation for U.S. CorrectChemo Laboratory 2
... the University of Wisconsin-Madison have identified dozens of clues ... ,The researchers identified nearly 40 genes that, ... the parasite from forming an infection in the brains ... of promising targets for developing drugs that could block ...
... brand ambassadors of India. But they could also prove a ... case of Thirumurthy Nakka Boomaiah , 35 and hailing ... ,He has been sentenced to 69 days in ... London to Philadelphia and assaulting flight attendants. But he has ...
... Michigan patients will have a new -- virtually pain ... Joseph Mercy Health System (SJMHS) announced today it will ... System on Wednesday, June 6th. ,This advanced ... body, including previously inoperable tumors, with astounding accuracy and ...
... The Seattle-based Infectious Disease Research Institute (IDRI) and ... entered into two research and development agreements ... Leishmaniasis and Leprosy, two 'neglected diseases' targeted by ... using Chembio's patented Dual Path immunoassay test platform ...
... blockbuster drug and greater reimbursement levels for the treatment ... smoking cessation and addiction treatments are expected to ... 2005 to more than $2.3 billion in 2010, according ... Analysis, a new study released today from Kalorama Information. ...
... A psychologist at the University College London has designed a ... can be distracted. ,Professor Nilli Lavie claims that ... tool during the recruitment process, and may be beneficial in ... ,"When you are easily distracted, you are more liable ...
Cached Medicine News:Health News:Mutant Parasites, Unable to Infect Hosts, Highlight Virulence Genes 2Health News:Indian Engineer Sentenced for Groping Women During Flight 2Health News:Advanced Cancer Treatment Brings New Hope to Michigan Patient 2Health News:IDRI and Chembio to Develop Tests for Leishmaniasis and Leprosy 2Health News:IDRI and Chembio to Develop Tests for Leishmaniasis and Leprosy 3Health News:Individuals Distraction can Be Measured by a Computer Based Test 2
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/zkkg9q/blood_processing ) has announced ... - Global Strategic Business Report" report to their offering. ... US, Canada , Japan ... , Latin America , and Rest of ... 2014 through 2020. Also, a seven-year historic analysis is provided ...
(Date:6/2/2015)... DUBLIN , June 02, 2015 Research and ... "Surgical Incision Closures - Global Strategic Business Report" ... comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America ... the worldwide markets for Surgical Incision Closures in US$ Million ...
(Date:6/2/2015)... , June 2, 2015 Intarcia Therapeutics, ... $75 million from its recently announced synthetic royalty / ... $300 million. Investors have purchased Convertible Limited Recourse Notes ... equal to 2.0% of any future global net sales ... fully paid. Investors also have the option, commencing upon ...
Breaking Medicine Technology:Blood Processing Supplies and Equipment Market - Global Strategic Business Report 2015-2020 2Blood Processing Supplies and Equipment Market - Global Strategic Business Report 2015-2020 3Surgical Incision Closures - Global Strategic Business Report 2015 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 3
... Wireless, internet-based ... provides compliance and ... complete system. The ... System incorporates communication ...
GelPort hand access laparoscopy combines the patient outcomes of minimally invasive surgery with the speed and precision of open surgery....
The CPAP TREND 110 delivers performance with quiet operation. Can be used together with the SomnoPlus CPAP Mask and AquaTrend Heated Humidifier....
... The SleepStyle 200 series offers ... integrated CPAP models. The design delivers ... patients. Performance features promote results in ... care. The strongest differentiator in the ...
Medicine Products: